The credit rating agency, CRISIL has reaffirmed ‘BB/stable’ rating assigned to Sandu Pharmaceutical’s long term bank facilities. Total bank loan facilities rated are worth Rs 13.35 crore.
Sandu Pharmaceuticals Ltd is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets.